A detailed history of Tealwood Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Tealwood Asset Management Inc holds 14,116 shares of NVO stock, worth $1.46 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
14,116
Previous 14,000 0.83%
Holding current value
$1.46 Million
Previous $2 Million 15.87%
% of portfolio
0.74%
Previous 1.2%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$119.07 - $145.42 $13,812 - $16,868
116 Added 0.83%
14,116 $1.68 Million
Q2 2024

Jul 09, 2024

SELL
$122.71 - $146.91 $9,448 - $11,312
-77 Reduced 0.55%
14,000 $2 Million
Q1 2024

Apr 11, 2024

SELL
$102.11 - $135.92 $847,206 - $1.13 Million
-8,297 Reduced 37.08%
14,077 $1.81 Million
Q4 2023

Jan 08, 2024

SELL
$87.78 - $105.45 $60,392 - $72,549
-688 Reduced 2.98%
22,374 $2.32 Million
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $1.04 Million - $2.28 Million
11,430 Added 98.26%
23,062 $2.1 Million
Q2 2023

Jul 26, 2023

SELL
$155.98 - $172.65 $25,892 - $28,659
-166 Reduced 1.41%
11,632 $1.88 Million
Q1 2023

Apr 12, 2023

SELL
$132.34 - $159.14 $63,655 - $76,546
-481 Reduced 3.92%
11,798 $1.88 Million
Q4 2022

Jan 17, 2023

SELL
$102.55 - $135.33 $35,995 - $47,500
-351 Reduced 2.78%
12,279 $1.66 Million
Q3 2022

Nov 16, 2022

SELL
$95.28 - $116.93 $2,763 - $3,390
-29 Reduced 0.23%
12,630 $1.26 Million
Q2 2022

Jul 20, 2022

SELL
$103.24 - $121.81 $12,492 - $14,739
-121 Reduced 0.95%
12,659 $1.41 Million
Q1 2022

May 02, 2022

BUY
$93.1 - $112.54 $4,748 - $5,739
51 Added 0.4%
12,780 $1.42 Million
Q4 2021

Mar 15, 2022

BUY
$95.88 - $117.08 $1.22 Million - $1.49 Million
12,729 New
12,729 $1.43 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tealwood Asset Management Inc Portfolio

Follow Tealwood Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tealwood Asset Management Inc with notifications on news.